@FiercePharma: Pfizer foils genericsmakers on Lyrica for 5 years. Last year's sales? $3.7B. Report | Follow @FiercePharma
@EricPFierce: WSJ: J&J, feds reach deal of up to $2.2 billion; J&J to pay $400 million fine but keep selling to federal programs. Story | Follow @EricPFierce
> Cubist Pharmaceuticals ($CBST) turned in an earning report that surprised analysts today, powered by a 20% jump in sales of its lead drug, antibiotic Cubicin. Story
> After 7 months, drugs issued through Express Scripts will again be covered when sold at Walgreens. Story
> The Korea Drug Development Fund, established last year with the aim of developing 10 new drugs by 2019, has selected CRO Parexel International as its first contract research service provider. Story
> Teva Pharmaceuticals, which has a neuroscience subsidiary, has donated $2.5 million to the Franklin Institute in Philadelphia to be used for the museum's "Your Brain" exhibit. Story
> BioRamo, a new company that will make liquid and semi-liquid drug products will invest $1.5 million on property in Fort Lauderdale, FL, and says it will open with 36 positions. Story
> The Licensing Board in the Ministry of National Regulations and Services in Pakistan this week granted or renewed 32 licenses for pharmaceutical companies. Story
Biotech News
@FierceBiotech: New compound nearly wipes out HIV in cells. More | Release | Follow @FierceBiotech
@JohnCFierce: Sanofi/Regeneron enrolling 22,000 patients for Phase III PCSK9 program. Let the LDL games begin. Release | Follow @JohnCFierce
@RyanMFierce: CHMP has backed approval of gene therapy for 1st time. How big of a "first" is this in biotech business? Release | Follow @RyanMFierce
> Vivus shares drop amid speculation about IP threats to diet drug. More
> Sanofi and Roche race to PhIII with drugs aimed at hot PCSK9 gene. News
> Bristol-Myers loses to Onyx in PhIII battle of drugs for liver cancer. Article
> New biotech deals scrape record low as VC groups lose steam. Report
@FierceMedDev: Roche Diagnostics plans to roll out a new interactive insulin pump system later this year. Article | Follow @FierceMedDev
@MarkHFierce: What were the top 10 VC medical device deals in H1 2012? Report | Follow @MarkHFierce
> Second Sight to argue for FDA approval of retinal prosthesis. Story
> Study: FDA device recall databases don't collect hacking data. Article
> Kips Bay Medical pursues new IDE for artery graft mesh device. More
> Med device VC deals are rising but the dollar volume remains flat. Report
And Finally... Amarin shares took a significant jump yesterday when a third-party contractor accidentally posted publicly a website that said the FDA had approved a heart drug, on which the agency is not expected rule until July 26. Story